Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC

Clinical trial NCT04557020 · UNKNOWN

Trial details

NCT number: NCT04557020
Sponsor: Jiangxi Provincial Cancer Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2020-12-30
Primary completion: 2026-03-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.